Subsequent RT-qPCR analyses of ovarian carcinoma tissues revealed that in Her2/neu-negative tumors, CDH13 was silenced through miRNA-mediated mechanisms, whereas in Her2/neu-positive tumors, these miRNAs were suppressed and CDH13 was repressed via promoter methylation. This evidence concerns the gene ERBB2 and ovarian carcinoma.